Tissue-specific Dose Optimization

Tissue-Specific Dose Optimization is a methodological framework within mutagen dose optimization that systematically tailors mutagen exposure levels to the physiological and genetic characteristics of distinct tissue types to maximize targeted mutagenic efficiency while minimizing nonspecific cellular damage.

3

Publications

115

Citations

18

Authors

7

Institutions

Publications per year

2017–2026

0

Authors

18

  1. JJ
    Jay J. Liao

    University of Washington, United States

    1 publications · 36 citations

    1

    h-index

  2. JM
    Jerker M. Olsson

    Karolinska Institutet, Sweden

    1 publications · 37 citations

    1

    h-index

  3. KK
    Konstantinos Kiakos

    University College London, United Kingdom

    1 publications · 42 citations

    1

    h-index

  4. PM
    Paul M. Loadman

    University of Bradford, United Kingdom

    1 publications · 42 citations

    1

    h-index

  5. MS
    Mark Searcey

    University of East Anglia, United Kingdom

    1 publications · 42 citations

    1

    h-index

1–5 of 18

Venues

  1. Medical Physics

    1 publications · 36 citations

    1

    h-index

  2. Chemical Communications

    ChemComm · 1 publications · 42 citations

    1

    h-index

  3. Bioelectrochemistry

    1 publications · 37 citations

    1

    h-index

  4. Health Physics

    1 publications · 11 citations

1–4